Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-12 · accession 0001415889-25-008117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-14 | 2025-03-12 | KNSA | Megna Michael R | CAO | M - OptEx | $11.10 | +9,051 | 35.6K | +34% | +$100.5K |
| D | 2025-03-14 | 2025-03-12 | KNSA | Megna Michael R | CAO | S - Sale+OE | $22.45 | -9,051 | 26.5K | -25% | -$203.2K |
| D | 2025-03-14 | 2025-03-12 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -9,051 | 13.8K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-03-12 | M | A | 9,051 | $11.10 | 35,579 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-03-12 | S | D | 9,051 | $22.45 | 26,528 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $22.45 and $22.465. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Share Option | 2025-03-12 | M | D | 9,051 | $0.00 | 13,763 | D | $11.10 · — to 2032-04-06 | 9,051 Class A Ordinary Share | (F3) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022. |